top
Please input keywords
OK
Database
Family Website
Eucure Biopharma
Biocytogen Boston Corp.
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Partnerships
Pipeline
RenMice™ HiTS Platform
Technology
Antibody discovery platforms
Antibody drug R&D
RenMice
Models
Animal/cell Models
Disease Models
Gene Editing
Investor Relations
Home
News events
Downloads
Poster Downloads
Media Center
News
Events
Webinar
Publication
Downloads
Poster Downloads
Brochure
2021
Humanized B-hC5AR1 mouse model for evaluation of anti-C5AR1 mAb in vivo efficacy
2021
Humanized IL6/hIL6R mouse model supports the evaluation of therapeutic drug candidates targeting human IL6 and IL6 receptor
2021
Anti-GCGR in vivo efficacy evaluated in a new humanized hGCGR mouse model
2021
Evaluating anti-SIRPα in vivo efficacy in humanized B-NDG hSIRPA mice and B-NDG hSIRPA/hCD47 mice
2021
Humanized IL17A/IL17F mouse model provides a preclinical tool for the evaluation of therapeutic drugs targeting to IL-17 pathway
2021
Novel human B7-H3 knock-in mice demonstrate efficacy of anti-B7-H3 immunotherapy in vivo
2021
Novel Engineered B-NDG B2M KO Mice Plus Shows Delayed GvHD response and Favorable GvL Immune Profiling After hPBMC Engraftment
2021
Human CD73 knock-in mice facilitate evaluation of in vivo efficacy of anti-human CD73 cancer immunotherapies
2021
A novel humanized B-hPD-1/hPD-L1/hTIGIT mouse model reveals enhanced efficacy of combined TIGIT and PD-L1 blockade against cancer
1
…
5
6
7
8
9
10
GO